Parkman Healthcare Partners’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.88M | Buy |
|
|||||
|
2025
Q2 | $4.88M | Sell |
|
|||||
|
2025
Q1 | $9.54M | Sell |
|
|||||
|
2024
Q4 | $19M | Buy |
|
|||||
|
2024
Q3 | $15.7M | Buy |
|
|||||
|
2024
Q2 | $6.33M | Buy |
|
|||||
|
2024
Q1 | $4.91M | Buy |
|
|||||
|
2023
Q4 | $4.73M | Buy |
|
|||||
|
2023
Q3 | $3.68M | Buy |
|
|||||
|
2023
Q2 | $2.44M | Buy |
|
|||||
|
2023
Q1 | $1.88M | Buy |
|
|||||
|
2022
Q4 | $1.81M | Sell |
|
|||||
|
2022
Q3 | $3.61M | Sell |
|
|||||
|
2022
Q2 | $4.34M | Buy |
|
|||||
|
2022
Q1 | $5.28M | Buy |
|
|||||
|
2021
Q4 | $4.74M | Sell |
|
|||||
|
2021
Q3 | $8.25M | Sell |
|
|||||
|
2021
Q2 | $6.77M | Sell |
|
|||||
|
2021
Q1 | $8.87M | Buy |
|
|||||
|
2020
Q4 | $6.02M | Sell |
|
|||||
|
2020
Q3 | $4.03M | Buy |
|
|||||
|
2020
Q2 | $3.96M | Buy |
|